• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 7
  3. Author

Online ISSN: 2515-8260

Volume9, Issue7

EGFR and CTNNB1 Gene Variants in Oral Squamous Cell Carcinoma and Fanconi Anemia Patients

    Dinara Nemetova, Selçuk Daşdemir, Bora Başaran, Yavuz Uyar, Tülin Tiraje Celkan, Şahin Öğreden,Haydar Murat Yener ,Tunç Fışgın ,Günter Hafız ,Mehmet Güven Günver , Arzu Pınar Erdem , Zişan Asal Kılıç , Nevin Yalman

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 7, Pages 929-937

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Oral squamous cell carcinoma (OSCC) is the most common epithelial malignancy in the oral cavity. The risk of the development of OSCC is high in Fanconi anemia (FA) patients owing to the DNA repair deficiency in somatic cells. EGFR, and CTNNB1 genes are suggested to be effective in development of OSCC. EGFR has been reported to have higher expression in OSCC, there are limited studies of EGFR and CTNNB1 gene polymorphisms in the development of OSCC. Therefore, we aimed to investigate the potential connection between EGFR rs845561 and CTNNB1 rs3864004 gene polymorphisms, and OSCC and FA. We performed polymerase chain reaction (PCR)/sanger sequencing for detection of the variations in these regions. EGFR rs845561, and CTNNB1 rs3864004 gene variants were compared between OSCC patients, and controls, no significant difference was detected (P>0.05). The EGFR rs845561 C allele frequency was lower in OSCC patients who had lymh node metastasis (P= 0.001), a significant association was detected between the EGFR rs845561 T allele frequency, and tumor perineural invasion (P= 0.05) in OSCC patients. CTNNB1 rs3864004 A allele frequency was associated with increased tumor invasion in OSCC patients (P= 0.01).
The CTNNB1 rs3864004 G/G genotype was higher in FA patients compared with the levels in the control group however, the A allele frequency was found lower (p:0.049). EGFR rs845561 gene variant showed no statistically significant difference between FA and control groups (p>0.05). EGFR T allele frequency was detected higher in FA patients who develop OSCC (p:0.03). The EGFR rs845561, and CTNNB1 rs3864004 gene variants may be suggested to contribute to the development of OSCC however, further studies are required
Keywords:
    Oral Squamous Cell Carcinoma Fanconi Anemia Epidermal Growth Factor Gene CTNNB1 polymorphism
  • PDF (377 K)
  • XML
(2022). EGFR and CTNNB1 Gene Variants in Oral Squamous Cell Carcinoma and Fanconi Anemia Patients. European Journal of Molecular & Clinical Medicine, 9(7), 929-937.
Dinara Nemetova, Selçuk Daşdemir, Bora Başaran, Yavuz Uyar, Tülin Tiraje Celkan, Şahin Öğreden,Haydar Murat Yener ,Tunç Fışgın ,Günter Hafız ,Mehmet Güven Günver , Arzu Pınar Erdem , Zişan Asal Kılıç , Nevin Yalman. "EGFR and CTNNB1 Gene Variants in Oral Squamous Cell Carcinoma and Fanconi Anemia Patients". European Journal of Molecular & Clinical Medicine, 9, 7, 2022, 929-937.
(2022). 'EGFR and CTNNB1 Gene Variants in Oral Squamous Cell Carcinoma and Fanconi Anemia Patients', European Journal of Molecular & Clinical Medicine, 9(7), pp. 929-937.
EGFR and CTNNB1 Gene Variants in Oral Squamous Cell Carcinoma and Fanconi Anemia Patients. European Journal of Molecular & Clinical Medicine, 2022; 9(7): 929-937.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 29
  • PDF Download: 99
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus